CAPTRUST Financial Advisors
SMMT icon

CAPTRUST Financial Advisors’s Summit Therapeutics SMMT Stock Holding History

CAPTRUST Financial Advisors’s Portfolio SMMT Stock Details SMMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-35,926
Closed -$90.2K – 2704
2023
Q2 		$90.2K Hold
35,926
– – ﹤0.01% 2387
2023
Q1 		$62.9K Buy
+35,926
New +$98K ﹤0.01% 2198
2022
Q4 		– Sell
-11,245
Closed -$13K – 2174
2022
Q3 		$13K Sell
11,245
-200
-2% -$226 ﹤0.01% 2025
2022
Q2 		$11K Buy
11,445
+200
+2% +$280 ﹤0.01% 3710
2022
Q1 		$28K Hold
11,245
– – ﹤0.01% 3203
2021
Q4 		$30K Hold
11,245
– – ﹤0.01% 3028
2021
Q3 		$56K Hold
11,245
– – ﹤0.01% 2501
2021
Q2 		$84K Buy
11,245
+845
+8% +$5.54K ﹤0.01% 2162
2021
Q1 		$61K Sell
10,400
-600
-5% -$3.87K ﹤0.01% 2302
2020
Q4 		$52K Hold
11,000
– – ﹤0.01% 1814
2020
Q3 		$37K Hold
11,000
– – ﹤0.01% 1739
2020
Q2 		$35K Buy
+11,000
New +$37.9K ﹤0.01% 1757

Other funds holding SMMT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 21.71% 1-Year Est. Return

CAPTRUST Financial Advisors's SMMT Position: Q3 2023 in Review

CAPTRUST Financial Advisors sold out of Summit Therapeutics (SMMT) in Q3 2023, closing a stake of 35,926 shares — an estimated $90.2K sold.

CAPTRUST Financial Advisors first reported a position in SMMT in Q2 2020 and held it in 12 quarters. The position peaked at $90.2K in Q2 2023. 93 funds tracked by Wall St. Rank hold SMMT as of Q3 2023.

  • CAPTRUST Financial Advisors reported no remaining Summit Therapeutics position as of Q3 2023 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 35,926 Summit Therapeutics shares in Q3 2023, an estimated $90.2K.
  • CAPTRUST Financial Advisors first reported a position in Summit Therapeutics in Q2 2020 and held it in 12 quarters.
  • CAPTRUST Financial Advisors's Summit Therapeutics position peaked at $90.2K in Q2 2023.
  • 93 funds tracked by Wall St. Rank held Summit Therapeutics as of Q3 2023.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2023, filed 15 Nov 2023.